Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
500 participants
INTERVENTIONAL
2015-01-31
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High-intensity Training Safely Improves Exercise Capacity in Heart, Lung, Kidney, and Liver Transplant Recipients: a Comparative Study
NCT03329586
Heart Transplant Patients, Health Status and Physical Activity
NCT05282342
Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Heart Transplantation
NCT00752336
Physical Activities in Daily Life After Lung Transplantation
NCT00395889
Prospective Intervention Study to Improve HRQoL and Exercise Tolerance After Lung Transplantation (Ergo-LTx)
NCT00753155
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It is increasingly recognized that non-pharmacological interventions hold the potential to improve long-term outcomes in transplantation as evidence shows that health behavior has been independently associated with transplant outcome (e.g. physical activity, non-smoking, medication adherence). Furthermore, exercise training interventions show positive outcome in a number of populations and limited research in transplantation shows positive outcomes in view of exercise capacity, muscle strength, cardiopulmonary variables and body composition. However, there is a lack of research that evaluates exercise training interventions in view of patient reported outcomes (PROs) in transplant recipients.
In the University Hospitals of Leuven (Belgium) a project named 'Transplantoux' has been launched to enhance physical activity and exercise capacity in transplant recipients. Transplant recipients participate in the 'Transplantoux' exercise training intervention for 6-months with the ultimate goal to cycle or hike up the Mont Ventoux (France) (distance: 25.9 km, mean slope: 4.4%). Extending on a previous safety feasibility study in which we demonstrated that selected Transplant recipients can safely participate in an intense exercise program and that exercise capacity was significantly improved after training. The primary aim of the current study is to evaluate the short- and long-term effect of the 'Transplantoux' intervention in view of selected Patient Reported Outcomes (PROs), i.e. perceived health-related quality-of-life, depressive symptomatology, stress and well-being, physical activity, social contacts and social support, and barriers and motivators to exercise.
The Transplantoux Health Evaluation Study (THES) uses a quasi-experimental design with three convenience samples: 1) a convenience sample of solid organ transplant (Tx)-recipients participating in the Transplantoux exercise training intervention, 2) matched control sample of Tx-recipients not participating in the Transplantoux exercise intervention, and 3) and a convenience sample of healthy controls participating in the Transplantoux exercise intervention. Selected PROs will be assessed using validated self-reported questionnaire. Data collection will be performed at baseline, 3 months (in the middle of the training intervention), 6 months (immediately following the intervention), 9 months (3 months follow-up period) and 12 months (6 months follow-up period).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tx exercise group
Convenience sample of solid organ transplant recipients (heart, kidney, lung, liver, pancreas, small bowel) participating in the Transplantoux exercise training intervention.
Intervention:
* Home-based individualized exercise training program
* Supervised group training sessions
* Climb of the Mont Ventoux
Home-based indiviualized exercise training program
Based on these results of the cardiopulmonary exercise test (CPET) on a cycle ergometer, an individualized training program (cycling/hiking) is prescribed by a physical therapist for 6 months (3x/week, ≥30min/session).
Supervised group training sessions
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Climb of the Mont Ventoux
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)
Tx matched control group
Controls are retrieved from the Leuven University Hospital heart, kidney, lung, liver, pancreas, small bowel transplant database and matched (1:4 matching) based on type of transplant, gender, age and time since transplant.
No interventions assigned to this group
Healthy exercise group
Convenience sample of health care providers (e.g. doctor, paramedic or medical companion involved in care programs for organ Tx) and patient's family members and friends participating in the Transplantoux exercise training intervention.
Intervention:
* Supervised group training sessions
* Climb of the mont ventoux
Supervised group training sessions
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Climb of the Mont Ventoux
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Home-based indiviualized exercise training program
Based on these results of the cardiopulmonary exercise test (CPET) on a cycle ergometer, an individualized training program (cycling/hiking) is prescribed by a physical therapist for 6 months (3x/week, ≥30min/session).
Supervised group training sessions
7 supervised group training sessions (cycling/hiking) are organized by a physiotherapist
Climb of the Mont Ventoux
Cycle or hike up the Mont Ventoux (25.7 km, average slope 4.5%)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 - 70 years
* More than 1y post-transplant
* Tx recipient (heart, lung, liver, kidney, pancreas or small bowel)
* Age between 18 - 70 years
* More than 1y post-transplant
* Age between 18 - 70 years
Exclusion Criteria
* Severe co-morbidity
* Contra-indication for severe exercise (e.g. cardiovascular disease)
* Insufficient knowledge of Dutch language
2. Tx matched control group
* Rejection last 6 months
* Insufficient knowledge of Dutch language
3. Healthy exercise group:
* Contra-indication for severe exercise
* Insufficient knowledge of Dutch language
18 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Basel
OTHER
Universitaire Ziekenhuizen KU Leuven
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diethard Monbaliu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University Hospital Leuven, Abdominal Transplant Surgery
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospitals Leuven
Leuven, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Ceulemans
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
THES1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.